BackEquillium Overview
Equillium Inc

Equillium Target Price

Analysts' average 12-month price target for Equillium is $4.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.29

Average Target Price

$4.00210.1% upside

1 analysts in the last 4 months

High: $4 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-13JefferiesRoger Song$4210.1% upsideOpen
2026-05-28Raymond James$7442.6% upsideOpen
2026-05-28Stifel NicolausAlex Thompson$5287.6% upsideOpen
2026-05-28Leerink PartnersThomas Smith$6365.1% upsideOpen
2026-04-23Oppenheimer$7442.6% upsideOpen
2026-04-13Raymond James$6365.1% upsideOpen
2025-03-28Leerink PartnersThomas Smith$122.5% downsideOpen

Equillium (EQ) FAQ

Equillium (EQ) currently reports a target price of $4. Use the charts on this page to explore Equillium's target price history and peer comparisons.

Analysts' average 12-month price target for Equillium is $4, about 210.1% upside from the current share price of $1.29. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $4, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Equillium, and consider following EQ for alerts when major investors trade the stock.

Equillium is classified in the Healthcare sector. On target price, it currently shows $4. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EQ with unrelated industries.